About
About CTSNet
Leadership
Participation
Sponsors
Industry Resources
Disclaimer
Policies
Contact Us
Journals
Journals
JANS
Books
For Authors
Submit Content
Submit Event
Submission Guidelines
Innovation Video Competition
CTSNet Resident Video Competition
Log In
Submit Content
Home
Learning Hub
Cardiac
Allied Health
Learning Hub
Jobs
U.S. Career Center
European Career Center
Events
Upcoming Events
Calendar View
Abstract Deadlines
Submit Event
Profiles
CTSNET Global
About
About CTSNet
Leadership
Participation
Sponsors
Industry Resources
Disclaimer
Policies
Contact Us
Journals
Journals
JANS
Books
For Authors
Submit Content
Submit Event
Submission Guidelines
Connecting the global cardiothoracic community
Sponsored in Part By
Home
Learning Hub
Cardiac
Thoracic
Congenital
Guest Editor Series
Roundtables and Webinars
Surgeon Spotlights
Meeting Presentations
For Residents
Allied Health
COVID-19
The Beat
CTSNet To Go
Jobs
U.S. Career Center
European Career Center
Events
Upcoming Events
Calendar View
Abstract Deadlines
Submit Event
Profiles
CTSNET Global
Sponsored
Esophagus - Cancer
Thoracic
Author Financial Conflicts of Interest, Industry Funding, and Clinical Practice Guidelines for Anticancer Drugs
By
Mark Ferguson
Nov. 11, 2014
0
Thoracic
Impact of Neoadjuvant Chemoradiotherapy on Postoperative Outcomes After Esophageal Cancer Resection: Results of a European Multicenter Study
By
Mark Ferguson
Oct. 8, 2014
0
Thoracic
Prognostic Classification of Histopathologic Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
By
Mark Ferguson
Oct. 8, 2014
0
Thoracic
Lymph Node Retrieval During Esophagectomy With and Without Neoadjuvant Chemoradiotherapy: Prognostic and Therapeutic Impact on Survival
By
Mark Ferguson
Oct. 8, 2014
0
Thoracic
Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer
By
Mark Ferguson
Oct. 8, 2014
0
Critical Care
The Comprehensive Complication Index: A Novel and More Sensitive Endpoint for Assessing Outcome and Reducing Sample Size in Randomized Controlled Trials
By
Mark Ferguson
Oct. 8, 2014
0
Thoracic
Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction
By
Mark Ferguson
Sep. 25, 2014
0
Thoracic
Importance of Surveillance and Success of Salvage Strategies After Definitive Chemoradiation in Patients With Esophageal Cancer
By
Mark Ferguson
Sep. 16, 2014
0
Thoracic
Treatment Trends, Risk of Lymph Node Metastasis, and Outcomes for Localized Esophageal Cancer
By
Marcelo Jimenez
Aug. 31, 2014
0
Esophagus
Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901
By
Mark Ferguson
Aug. 9, 2014
0
Thoracic
Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction
By
Mark Ferguson
Jul. 29, 2014
0
Thoracic
Clinical Staging of Patients with Early Esophageal Adenocarcinoma: Does FDG-PET/CT Have a Role?
By
Mark Ferguson
Jul. 28, 2014
0
1
…
4
5
6
7
8
…
10
Log In
New to CTSNet?
Sign Up
Email
Password
Remember me
Log In
Forgot Password